CD8A and neoplasm: While our studies and those of Solomon et al. [25] using a mAb with similar properties clearly demonstrated the activation of CD8+ Tconv cells after deletion of Treg from the TME, neither of the studies demonstrated effects on tumor size or potential for metastasis.